Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-13 Sale | 2024-03-15 8:00 pm | enVVeno Medical Corp | NVNO | Alavi Hamed Chief Technology Officer | 8,334 | $6.22 | $51,837 | 91,666 (Direct) | View |
| 2022-08-16 Purchase | 2022-08-18 4:05 pm | enVVeno Medical Corp | NVNO | Duhay Francis Director | 7,751 | $6.14 | $47,591 | 20,911 (Direct) | View |
| 2022-06-30 Purchase | 2022-07-01 4:05 pm | enVVeno Medical Corp | NVNO | Shrivastava Sanjay Director | 1,000 | $3.85 | $3,850 | 3,888 (Direct) | View |
| 2022-06-27 Purchase | 2022-06-28 4:05 pm | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 2,500 | $3.8 | $9,500 | 210,236 (Direct) | View |
| 2021-11-19 Purchase | 2021-11-19 5:27 pm | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW CEO | 2,000 | $7.43 | $14,860 | 7,736 (Direct) | View |
| 2021-11-16 Purchase | 2021-11-18 4:24 pm | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW CEO | 2,000 | $7.87 | $15,740 | 5,736 (Direct) | View |
| 2021-08-25 Purchase | 2021-08-27 3:19 pm | Hancock Jaffe Laboratories Inc. | HJLI | Jenusaitis Matthew Director | 1,300 | $7.7 | $10,010 | 4,842 (Direct) | View |
| 2021-06-16 Purchase | 2021-06-21 7:16 pm | Hancock Jaffe Laboratories Inc. | HJLI | Gray Robert Director | 2,000 | $6.25 | $12,500 | 5,572 (Direct) | View |
| 2021-05-21 Purchase | 2021-05-25 5:15 pm | Hancock Jaffe Laboratories Inc. | HJLI | Glickman Marc H. SVP & Chief Medical Officer | 1,600 | $5.9 | $9,440 | 1,600 (Direct) | View |
| 2021-05-18 Purchase | 2021-05-19 8:20 pm | Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW Chief Executive Officer | 3,000 | $5.47 | $16,410 | 3,736 (Direct) | View |
| 2021-05-17 Purchase | 2021-05-19 8:18 pm | Hancock Jaffe Laboratories Inc. | HJLI | Duhay Francis Director | 9,492 | $5.33 | $50,592 | 13,160 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-13 Exercise | 2024-03-15 8:00 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Alavi Hamed Chief Technology Officer | 8,334 | $0 | 91,666 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 8:00 pm | N/A N/A | enVVeno Medical Corp | NVNO | Alavi Hamed Chief Technology Officer | 8,334 | $3.59 | 91,666 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:07 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Glynn Craig Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:06 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director | 13,856 | $0 | 13,856 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:05 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Alavi Hamed Chief Technology Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:05 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Glickman Marc H. SVP & Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:05 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Gray Robert Director | 13,856 | $0 | 13,856 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:05 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Shrivastava Sanjay Director | 13,856 | $0 | 13,856 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:05 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | Duhay Francis Director | 13,856 | $0 | 13,856 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:05 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 300,000 | $0 | 300,000 (Direct) | View |
Ownership | 2023-01-31 9:56 pm | N/A 2032-11-30 | enVVeno Medical Corp | NVNO | Alavi Hamed Chief Technology Officer | 0 | $0 | 603,925 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:30 pm | N/A 2032-11-30 | enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director | 8,403 | $0 | 8,403 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:30 pm | N/A 2032-11-30 | enVVeno Medical Corp | NVNO | Shrivastava Sanjay Director | 8,403 | $0 | 8,403 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:30 pm | N/A 2032-11-30 | enVVeno Medical Corp | NVNO | Gray Robert Director | 8,403 | $0 | 8,403 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:30 pm | N/A 2032-11-30 | enVVeno Medical Corp | NVNO | Duhay Francis Director | 8,403 | $0 | 8,403 (Direct) | View |
| 2022-09-13 Exercise | 2022-09-16 4:05 pm | N/A N/A | enVVeno Medical Corp | NVNO | Gray Robert Director | 1,041 | $0 | 7,655 (Direct) | View |
| 2022-09-13 Exercise | 2022-09-16 4:05 pm | N/A N/A | enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director | 1,041 | $0 | 6,925 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 6:27 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 549,781 | $0 | 557,517 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 6:26 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | Glickman Marc H. SVP & Chief Medical Officer | 365,700 | $0 | 367,300 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 6:25 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | Glynn Craig Chief Financial Officer | 175,925 | $0 | 175,925 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 4:05 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | Gray Robert Director | 7,211 | $0 | 7,211 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 4:05 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | Duhay Francis Director | 7,211 | $0 | 7,211 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 4:05 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director | 7,211 | $0 | 7,211 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 4:05 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | Shrivastava Sanjay Director | 7,211 | $0 | 7,211 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-18 4:30 pm | N/A N/A | enVVeno Medical Corp | NVNO | Shrivastava Sanjay Director | 388 | $0 | 2,888 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 9:50 pm | N/A N/A | Hancock Jaffe Laboratories Inc. | HIJI | Jenusaitis Matthew Director | 1,042 | $0 | 7,968 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 9:50 pm | N/A N/A | Hancock Jaffe Laboratories Inc. | HIJI | Gray Robert Director | 1,042 | $0 | 8,698 (Direct) | View |
| 2020-07-18 Option Award | 2021-02-23 5:21 pm | N/A 2030-07-18 | Hancock Jaffe Laboratories Inc. | HJLI | Glynn Craig Chief Financial Officer | 328,000 | $0 | 4,324 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 9:59 pm | N/A 2031-02-18 | Hancock Jaffe Laboratories Inc. | HJLI | Duhay Francis Director | 5,673 | $0 | 5,673 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 9:58 pm | N/A 2031-02-18 | Hancock Jaffe Laboratories Inc. | HJLI | Jenusaitis Matthew Director | 5,673 | $0 | 5,673 (Direct) | View |